These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28111263)

  • 41. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-standing therapy of the metabolic syndrome in diabetics after coronary artery bypass surgery].
    Steinmetz A
    Clin Res Cardiol; 2006 Jan; 95 Suppl 1():i110-6. PubMed ID: 16598537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Association of physical inactivity with obesity, diabetes, hypertension and metabolic syndrome in the chilean population].
    Díaz-Martínez X; Petermann F; Leiva AM; Garrido-Méndez A; Salas-Bravo C; Martínez MA; Labraña AM; Duran E; Valdivia-Moral P; Zagalaz ML; Poblete-Valderrama F; Alvarez C; Celis-Morales C
    Rev Med Chil; 2018 May; 146(5):585-595. PubMed ID: 30148922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Obesity and metabolic syndrome: potential benefit from specific nutritional components.
    Abete I; Goyenechea E; Zulet MA; Martínez JA
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21 Suppl 2():B1-15. PubMed ID: 21764273
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of non-alcoholic fatty liver disease.
    Dyson J; Day C
    Dig Dis; 2014; 32(5):597-604. PubMed ID: 25034293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-alcoholic fatty liver disease in obese children and the relationship between metabolic syndrome criteria.
    Boyraz M; Hatipoğlu N; Sarı E; Akçay A; Taşkın N; Ulucan K; Akçay T
    Obes Res Clin Pract; 2014; 8(4):e356-63. PubMed ID: 25091357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.
    Mann JP; Goonetilleke R; McKiernan P
    Arch Dis Child; 2015 Jul; 100(7):673-7. PubMed ID: 25633064
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Metabolic syndrome in childhood and adolescence].
    Barkai L; Paragh G
    Orv Hetil; 2006 Feb; 147(6):243-50. PubMed ID: 16610614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
    Kim D; Touros A; Kim WR
    Clin Liver Dis; 2018 Feb; 22(1):133-140. PubMed ID: 29128053
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pathophysiology of the metabolic syndrome.
    McCracken E; Monaghan M; Sreenivasan S
    Clin Dermatol; 2018; 36(1):14-20. PubMed ID: 29241747
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic complications of obesity in childhood and adolescence: more than just diabetes.
    Nathan BM; Moran A
    Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):21-9. PubMed ID: 18185059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Obesity and the metabolic syndrome in children and adolescents].
    Knerr I
    MMW Fortschr Med; 2004 Aug; 146(33-34):41-3. PubMed ID: 15526625
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction.
    Federico A; Dallio M; Masarone M; Persico M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4731-4741. PubMed ID: 27906428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease risks of childhood obesity in China.
    Li YP; Yang XG; Zhai FY; Piao JH; Zhao WH; Zhang J; Ma GS
    Biomed Environ Sci; 2005 Dec; 18(6):401-10. PubMed ID: 16544522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
    Valenti L; Bugianesi E; Pajvani U; Targher G
    Liver Int; 2016 Nov; 36(11):1563-1579. PubMed ID: 27276701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of metabolic syndrome in children and adolescents.
    Pacifico L; Anania C; Martino F; Poggiogalle E; Chiarelli F; Arca M; Chiesa C
    Nutr Metab Cardiovasc Dis; 2011 Jun; 21(6):455-66. PubMed ID: 21565479
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.